Markus Sieger, Director at Cyclo Therapeutics, Inc. (CYTH), bought 10,000 shares at $2.73 ($27K) on 2022-03-29, disclosed to the SEC on 2022-03-30.
Open-market purchase of $27k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| CYTH | BUY | 2021-01-27 | $64K | — | Filing → |
| CTDH | BUY | 2020-04-27 | $50K | — | Filing → |
| CTDH | BUY | 2019-08-26 | $22K | — | Filing → |